SCOPUS 정보 검색 플랫폼

Science Signaling

Volumn 5, Issue 254, 2012, Pages

Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"

(6) Burtness, Barbara a Marur, Shanthi b Bauman, Julie E c Golemis, Erica A a Mehra, Ranee a Cohen, Steven J a

a FOX CHASE CANCER CENTER (United States)

b JOHNS HOPKINS UNIVERSITY (United States)

c UNIVERSITY OF NEW MEXICO (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; TOLL LIKE RECEPTOR 3;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CANCER THERAPY; GASTROENTERITIS; HUMAN; INFECTION RISK; INNATE IMMUNITY; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR IMMUNITY;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; IMMUNITY, INNATE; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SIROLIMUS; TOLL-LIKE RECEPTOR 3;

MAMMALIA;

EID: 84871119463 PISSN: 19450877 EISSN: 19379145 Source Type: Journal
DOI: 10.1126/scisignal.2003734 Document Type: Article

Times cited : (14)

References (4)

1
- 84864120697
- Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling
- M. Yamashita, S. Chattopadhyay, V. Fensterl, P. Saikia, J. L. Wetzel, G. C. Sen, Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci. Signal. 5, ra50 (2012).
- (2012) Sci. Signal. , vol.5
- Yamashita, M.¹ Chattopadhyay, S.² Fensterl, V.³ Saikia, P.⁴ Wetzel, J.L.⁵ Sen, G.C.⁶

2
- 54949109311
- The TSC-mTOR signaling pathway regulates the innate infl ammatory response
- T. Weichhart, G. Costantino, M. Poglitsch, M. Rosner, M. Zeyda, K. M. Stuhlmeier, T. Kolbe, T. M. Stulnig, W. H. Hörl, M. Hengstschläger, M. Müller, M. D. Säemann, The TSC-mTOR signaling pathway regulates the innate infl ammatory response. Immunity 29, 565-577 (2008).
- (2008) Immunity , vol.29 , pp. 565-577
- Weichhart, T.¹ Costantino, G.² Poglitsch, M.³ Rosner, M.⁴ Zeyda, M.⁵ Stuhlmeier, K.M.⁶ Kolbe, T.⁷ Stulnig, T.M.⁸ Hörl, W.H.⁹ Hengstschläger, M.¹⁰ Müller, M.¹¹ Säemann, M.D.¹²

3
- 79953183347
- Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of plat-inum- based chemotherapy: An open-label, randomised phase 3 trial
- J. P. Machiels, S. Subramanian, A. Ruzsa, G. Repassy, I. Lifirenko, A. Flygare, P. Sørensen, T. Nielsen, S. Lisby, P. M. Clement, Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of plat-inum- based chemotherapy: an open-label, randomised phase 3 trial. Lancet Oncol. 12, 333-343 (2011).
- (2011) Lancet Oncol. , vol.12 , pp. 333-343
- Machiels, J.P.¹ Subramanian, S.² Ruzsa, A.³ Repassy, G.⁴ Lifirenko, I.⁵ Flygare, A.⁶ Sørensen, P.⁷ Nielsen, T.⁸ Lisby, S.⁹ Clement, P.M.¹⁰

4
- 84858696578
- Antiviral applications of Toll-like receptor agonists
- N. J. Horscroft, D. C. Pryde, H. Bright, Antiviral applications of Toll-like receptor agonists. J. Antimicrob. Chemother. 67, 789-801 (2012).
- (2012) J. Antimicrob. Chemother. , vol.67 , pp. 789-801
- Horscroft, N.J.¹ Pryde, D.C.² Bright, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.